Protein in blood may predict how seniors react to sedation

NCT ID NCT07280663

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed early-phase study looked at 128 older adults (60+) having knee replacement surgery. Researchers measured a protein called neurofilament light chain in the blood and checked how sensitive patients were to the sedative remazolam. The goal was to see if higher protein levels—which can indicate nerve damage—relate to needing less sedation or having more side effects. The findings could help doctors personalize anesthesia for elderly patients, but the study is small and only explores a possible link, not a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remazolam
What this could lead to
If successful, this could help anesthesiologists tailor sedation doses for older patients, potentially reducing risks like confusion or falls after surgery.
What could go wrong
This is a very early, small study (128 people) that only looks for a link between a protein and drug sensitivity. It does not test a new treatment, so direct benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OLD AGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Second Hospital of Shanxi Medical University

    Taiyuan, Shanxi, 030001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.